CSI Market
Sign In | Register

Eli Lilly (LLY) Annual Balance Sheets

Annual · GAAP · USD millions
Access LLY quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Eli Lilly manages its resources, obligations, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7,268.00
Short-term Investments, Total0.00
Cash & Short-term Investments7,268.00
Accounts receivable17,760.00
Other Receivables, Net, Current2,395.00
Inventories13,744.00
Other current assets147.00
Prepaid Expense, Current AS14,315.00
Total Current Assets55,629.00
Equipment/Property/Plant Net24,675.00
Goodwill net5,898.00
Intangible Assets6,521.00
Long-term investments2,802.00
Other Assets19,753.00
Total Assets112,476.00
Liabilities
Accounts Payable, Current AC5,379.00
Employee-related Liabilities, Current AC2,375.00
Debt, Current LI1,635.00
Other current liabilities8,457.00
Taxes Payable, Current, Total0.00
Total Current Liabilities35,228.00
Long-term debt40,868.00
Total Long-term Debt40,868.00
Combined Long+Short Total Debt (filer-reported)42,503.00
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE0.00
Accrued Income Taxes, Noncurrent AC15,875.00
Other longterm liabilities0.00
Sales Rebates And Discounts17,382.00
Total Liabilities81,971.00
Stockholders' Equity
Common Stock Shares Held In Employee Trust-3,013.00
Common Stock Value590.00
Treasury Stock Value0.00
Additional Paid In Capital Common Stock7,346.00
Retained Earnings / Accumulated Deficit22.00
Other Equity21,590.00
Common Stockholder's Equity26,535.00
Non-controlling interests & other0.00
Total Stockholder's Equity26,535.00
Liabilities & Stockholder's Equity112,476.00
4 historic quarters locked

Sign in to unlock the full Eli Lilly balance sheet history.

Sign In Create Free Account

About Eli Lilly and Co Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: lly-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000059478-26-000013

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License